Linda Lindberg, Jining Liu, Jan Holgersson
AbSorber AB, Stockholm, Sweden.
Methods in molecular biology (Clifton, N.J.) 2013Metabolic engineering of mammalian cells for optimized glycosylation is usually done to improve activity and the pharmacokinetic features of glycoprotein therapeutics. The field is mainly focused around engineering of N-glycans. We have created a platform in which recombinant mucin-type immunoglobulin fusion proteins are used as scaffolds for multivalent expression of O-glycans with diagnostic or therapeutic potential. The methods used to make stable CHO cell lines secreting a mucin-type fusion protein with blood group A or B determinants following expression of up to five different cDNAs are described.
Linda Lindberg, Jining Liu, Jan Holgersson. Engineering of therapeutic and diagnostic O-glycans on recombinant mucin-type immunoglobulin fusion proteins expressed in CHO cells. Methods in molecular biology (Clifton, N.J.). 2013;988:3-17
PMID: 23475710
View Full Text